A rational approach to the planning and analysis of electrocardiogram safety data in clinical trials*

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.16, Iss.3, 2002-06, pp. : 133-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Handling Missing Data in Vaccine Clinical Trials for Immunogenicity and Safety Evaluation

By Li Xiaoming Wang William Liu Guanghan Chan Ivan

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 294-310

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Review of: “Data and Safety Monitoring Committees in Clinical Trials, by J. Herson”

By Gallo Paul

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 1168-1171

Taylor & Francis Ltd

Access to resources Recommend Favorite

Memantine for the Treatment of Alzheimer's Disease: Tolerability and Safety Data from Clinical Trials

By Farlow Martin R.

Drug Safety, Vol. 31, Iss. 7, 2008-01 ,pp. : 577-585

Adis International

Access to resources Recommend Favorite

Moxifloxacin Safety: An Analysis of 14 Years of Clinical Data

By Tulkens Paul M.

Drugs in R&D, Vol. 12, Iss. 2, 2012-06 ,pp. : 71-100

Adis International

Access to resources Recommend Favorite

On the Lower Predictive Bound Approach for Noninferiority Clinical Trials with Binary Data

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 6, 2014-11 ,pp. : 1225-1238

Taylor & Francis Ltd

Access to resources Recommend Favorite